The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Director Shareholding

27 Apr 2005 10:32

Akers Biosciences, Inc.27 April 2005 AKERS BIOSCIENCES, INC. DIRECTOR'S DEALING Akers Biosciences, Inc. ("the Company") today announces that on 26 April 2005,David Wilbraham, non-executive chairman, purchased 50,000 shares of theCompany's common stock, no par value, at 49 pence per share. Following this purchase, Mr. Wilbraham is the beneficial owner of 300,000 commonshares representing 0.63% of the issued capital Contact: Paul B. Freedman - 00 1 856 848 2116 27 April 2005 End This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.